Results 31 to 40 of about 278,205 (268)

Human Vitamin K 2,3-Epoxide Reductase Complex Subunit 1-like 1 (VKORC1L1) Mediates Vitamin K-dependent Intracellular Antioxidant Function [PDF]

open access: yesJournal of Biological Chemistry, 2011
Human vitamin K 2,3-epoxide reductase complex subunit 1-like 1 (VKORC1L1), expressed in HEK 293T cells and localized exclusively to membranes of the endoplasmic reticulum, was found to support both vitamin K 2,3-epoxide reductase (VKOR) and vitamin K reductase enzymatic activities.
Philipp, Westhofen   +8 more
openaire   +2 more sources

Three phosphatase families form a community: The phosphohydrolases that act upon inositol pyrophosphates

open access: yesFEBS Letters, EarlyView.
Inositol pyrophosphates are energy‐rich signaling molecules that perform critical functions in cells. Three different families of phosphatases hydrolyze the β phosphate of the inositol pyrophosphate molecules: two have narrow specificities and one is promiscuous.
Ronda J. Rolfes
wiley   +1 more source

Congenital Vitamin K-Dependent Clotting Factors Deficiency Type 1: A Rare Bleeding Disorder

open access: yesDubai Medical Journal, 2020
Combined deficiency of vitamin K-dependent clotting factors is usually an acquired clinical problem, often resulting from liver disease, malabsorption or warfarin overdose. However, an inherited form of the disease is very rare.
Sura Ahmed Al-Doory   +3 more
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

The role of vitamin K in the pathology of newborns and infants (literature review)

open access: yesZdorovʹe Rebenka
The presented review considers modern views on the mechanism of development, prevention and treatment of vitamin K deficiency bleedings in newborns and infants. The search for literary sources was carried out in Scopus, Web of Science, Medscape, UpToDate,
Y.V. Marushko   +3 more
doaj   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Association between dietary vitamin K intake and lipid metabolism among populations with cardiovascular disease

open access: yesFrontiers in Nutrition
BackgroundThe objective of this investigation was to examine the correlation between intake of dietary vitamin K and lipid metabolism in cardiovascular disease populations.MethodsThe data for this investigation were obtained from the National Health and ...
Tao Liu   +3 more
doaj   +1 more source

Dietary reference values for vitamin K

open access: yesEFSA Journal, 2017
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) derives dietary reference values (DRVs) for vitamin K.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)   +27 more
doaj   +1 more source

EXPERIENCE IN THE MANAGEMENT OF OCCLUSIVE DEEP VENUS THROMBOSIS WITH ENOXAPARININ SODIUM IN OUTPATIENT SETTINGS

open access: yesАтеротромбоз, 2017
The article presents the experience in management of occlusive deep vein thrombosis with enoxaparin sodium in outpatient settings. The study included two groups of patients: the patients of the first group received unfractionated heparin for 10-14 days ...
A. M. ZUDIN, A. G. FAIBUSHEVICH
doaj   +1 more source

Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease

open access: yesFEBS Open Bio, EarlyView.
Repair of neuronal DNA damage in Alzheimer's disease by KCL‐286. (A) Amyloid‐β oligomers and plaques impair neuronal DNA repair pathways, leading to DNA double‐strand breaks and glial activation. (B) KCL‐286 activates RARβ/RXR signalling via retinoic acid response elements (RAREs), associated with increased BRCA1 expression, enhanced DNA repair and ...
Natasha Hill   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy